132 related articles for article (PubMed ID: 35149891)
1. Desmoplastic reactions and epithelial-mesenchymal transition proteins in stages II and III colorectal cancer: association with and prognostic value for disease-free survival.
Hashimoto M; Uesugi N; Sugai M; Ito K; Yanagawa N; Otsuka K; Kajiwara Y; Ueno H; Sasaki A; Sugai T
Virchows Arch; 2022 Apr; 480(4):793-805. PubMed ID: 35149891
[TBL] [Abstract][Full Text] [Related]
2. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
[TBL] [Abstract][Full Text] [Related]
3. Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.
González IA; Bauer PS; Liu J; Chatterjee D
Histopathology; 2021 Jan; 78(2):252-264. PubMed ID: 32654226
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer.
Ueno H; Shinto E; Kajiwara Y; Fukazawa S; Shimazaki H; Yamamoto J; Hase K
Br J Cancer; 2014 Nov; 111(11):2082-90. PubMed ID: 25247323
[TBL] [Abstract][Full Text] [Related]
5. Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures.
Yang YC; Chien MH; Lai TC; Su CY; Jan YH; Hsiao M; Chen CL
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316576
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9.
Ao T; Mochizuki S; Kajiwara Y; Yonemura K; Shiraishi T; Nagata K; Shinto E; Okamoto K; Nearchou IP; Shimazaki H; Kishi Y; Okada Y; Ueno H
Int J Cancer; 2022 May; 150(10):1706-1721. PubMed ID: 35080810
[TBL] [Abstract][Full Text] [Related]
7. Histologic categorization of desmoplastic reaction: its relevance to the colorectal cancer microenvironment and prognosis.
Ueno H; Shinto E; Shimazaki H; Kajiwara Y; Sueyama T; Yamamoto J; Hase K
Ann Surg Oncol; 2015 May; 22(5):1504-12. PubMed ID: 25395146
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation.
Yang Z; Zhang C; Qi W; Cui C; Cui Y; Xuan Y
Exp Mol Pathol; 2018 Oct; 105(2):216-222. PubMed ID: 30170017
[TBL] [Abstract][Full Text] [Related]
9. A Multicenter Study of the Prognostic Value of Desmoplastic Reaction Categorization in Stage II Colorectal Cancer.
Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Kajiwara Y; Okamoto K; Mochizuki S; Tsujimoto H; Shinto E
Am J Surg Pathol; 2019 Aug; 43(8):1015-1022. PubMed ID: 31094924
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
11. Role of SSH1 in colorectal cancer prognosis and tumor progression.
Song X; Xie D; Xia X; Tan F; Pei Q; Li Y; Zhou Z; Zhou Y; Li C; Wang K; Pei H
J Gastroenterol Hepatol; 2020 Jul; 35(7):1180-1188. PubMed ID: 32020663
[TBL] [Abstract][Full Text] [Related]
12. Desmoplastic Pattern at the Tumor Front Defines Poor-prognosis Subtypes of Colorectal Cancer.
Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J
Am J Surg Pathol; 2017 Nov; 41(11):1506-1512. PubMed ID: 28877064
[TBL] [Abstract][Full Text] [Related]
13. Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorization.
Ueno H; Sekine S; Oshiro T; Kanemitsu Y; Hamaguchi T; Shida D; Takashima A; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J; Shimada Y
Surgery; 2018 Apr; 163(4):777-783. PubMed ID: 29162344
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
15. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
[TBL] [Abstract][Full Text] [Related]
16. Morphological consistency of desmoplastic reactions between the primary colorectal cancer lesion and associated metastatic lesions.
Ao T; Kajiwara Y; Yonemura K; Shinto E; Mochizuki S; Okamoto K; Kishi Y; Ueno H
Virchows Arch; 2020 Jul; 477(1):47-55. PubMed ID: 31932918
[TBL] [Abstract][Full Text] [Related]
17. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
[TBL] [Abstract][Full Text] [Related]
18. Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
Wang K; Song K; Ma Z; Yao Y; Liu C; Yang J; Xiao H; Zhang J; Zhang Y; Zhao W
Br J Cancer; 2020 Aug; 123(3):410-417. PubMed ID: 32435058
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
[TBL] [Abstract][Full Text] [Related]
20. Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).
Chang YJ; Cheng YW; Lin RK; Huang CC; Chen WT; Ke TW; Wei PL
PLoS One; 2016; 11(8):e0160550. PubMed ID: 27512995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]